Dr. Caterina Marchiò is an experimental pathologist leading the research programme of the Pathology Unit at the Candiolo Cancer Institute. Her research interests span from histopathogenesis of breast carcinomas to molecular pathology of histologic types of breast cancer and genetics of HER2-positive and HER2-low carcinomas.

Dr. Marchiò completed her undergraduate training at the University of Turin and undertook a PhD programme during which she trained at Breakthrough Breast Cancer Research Centre – Institute of Cancer Research in London. Upon the completion of the PhD she undertook her clinical training in Pathology at the University of Turin. She was then appointed Associate Professor of Pathology for the University of Turin at the Candiolo Cancer Institute FPO-IRCCS.

Dr. Marchiò is devoted to deconvolute the complexity of pathology to foster precision medicine. She is also actively involved in the standardisation of preanalytical conditions of tissue sample management and processing to guarantee quality of DNA, RNA and antigens.

She has been involved in the ESMO Translational Research and Precision Medicine Working Group and led the consensus recommendation paper on the standard methods to detect NTRK fusions in daily practice and clinical research.